logo
The neuroscientist working on ‘zapping' away unwanted memories

The neuroscientist working on ‘zapping' away unwanted memories

Yahoo17-06-2025
Think of your happiest memory. A wedding, your child's birth, or maybe just a perfect night out with friends. Sit with it for a moment. Remember the details. What were you wearing? What did it smell like? How did it make you feel?
Now do the opposite. Think of a sad memory—the loss of a loved one, getting laid off, or a painful breakup. Sit with this one too.
Which would you rather keep?
Of course, you want the happy memory, the one that made you feel good and joyful about life. Yet, the painful ones linger for years and sometimes decades, like bruises beneath the surface. If you could choose, would you keep them—or delete them entirely?
If this is all starting to sound like something out of Eternal Sunshine of the Spotless Mind or Inception, you wouldn't be too far off—and Steve Ramirez would agree with you. Ramirez is a neuroscientist at Boston University and National Geographic Explorer whose research occurs on the bleeding edge of memory science. He's perhaps best known for studies he helped conduct that showed that it was possible to implant a false memory in mice. The findings were published in the journal Science in 2013 and the Royal Society in 2014.
His research is built on a central truth: Memory is fickle. It changes and morphs every time we recall it. Ramirez compares it to hitting 'Save As' on a Word document. Everytime we retrieve a memory, we change it slightly. Ramirez is exploring whether we can harness that 'Save As' process—intentionally rewriting our memories instead of letting them change by accident. So far, he's figured out how to do something even more surprising: not destroy a bad memory, but create a new one.
'We know memories are malleable, and susceptible to modification,' says Ramirez. 'Every time they're recalled, they're being saved and edited with bits and pieces. We wanted to see if we could do that in the lab. Because if we could do that directly in the lab and brain, then we can really get a higher resolution snapshot of how memories work when they're being warped or when they're being modified.'
The team's foundational study came in a 2012 paper published in Nature where they identified and activated a cluster of neurons in mice brains that encoded a fear memory—specifically, a mild foot shock. To do so, the researchers genetically engineered the mice so that memory-related neurons become light sensitive. The creatures were then placed into a box and received a foot shock—resulting in the memory of that shock becoming encoded in the light-sensitive brain cells.
The team then surgically implanted a tiny fiber-optic cable into the skull of each mouse that they could use to shine a laser into its brain. When they turned it on, it activated the bad memory on command like flipping a switch.
Next they wanted to see if they could create a false memory. For this, they put a mouse in a safe box and let it explore. The next day, they placed the mouse in a different box, triggered the memory of the safe box by shooting a laser over its brain, and simultaneously gave it a foot shock. When they later returned the mouse in the first box, it froze in fear—even though it never received a shock in that box.
The team had, in effect, implanted a false memory in the mice.
'The key thing with that experiment was that we showed that we could artificially activate a memory while the animal was experiencing something. Later, that new, updated version was the animal's last recorded version of that memory,' he explains. 'The mouse was scared in an environment where, technically, nothing bad happened.'
Between the lasers, false memories, and shocking experiments, you'd be forgiven if you thought this was getting pretty sci-fi. Ramirez embraces the comparison as his work often brushes up against science fiction in big ways.
'I think science fiction and science reality are in lockstep, often influencing each other in surprising and unpredictable ways,' Ramirez says. 'What sci-fi can get 'wrong' sometimes is inevitable, but the work it inspires and the dreams and visions sci-fi can conjure up in people is practically limitless, and I love it for that very reason.'
Still, it can seem scary, especially when you consider the potential applications to humans. But Ramirez says that memory manipulation would take a decidedly less invasive approach for people—no brain lasers required. Instead, if you want to activate a happy memory in another person, all you have to do is ask them about it. (Remember the beginning of the story—or did you forget?)
'We can update a seemingly safe memory into something negative,' he says, referring to the foot shock test. 'But what about the opposite: Can we turn a negative memory into a positive memory?'
Despite the pop-culture comparisons to Inception or Eternal Sunshine, Ramirez's real-world applications are far less cinematic—and arguably more profound. Instead, his work is laying the groundwork for helping people with PTSD process harmful memories, or those with neurodegenerative disorders like Alzheimer's and dementia live longer, better lives.
In a forthcoming paper currently under peer review, his team claims they were able to identify where exactly a memory will form in the brain days before it even happens. It's like being able to predict where lightning is about to strike before the storm even gathers. This might allow future clinicians to anticipate the effects of Alzheimer's, Parkinson's, and dementia before they occur.
'Imagine being able to make a Google Maps for memory, but with the level of individual brain cells,' he says. 'You could say, 'This is a positive memory in the brain. It's located here in this 3D web of activity. We can zoom into it here and it looks like something is misfiring, and that might be the remnants of some kind of cognitive decline or memory loss, or amnesia, or Alzheimer's.''
We're still a long way away from a Google Maps for memory. However, Ramirez is quick to point out that his field of research is still in its infancy. He puts it this way: the study of neuroscience is roughly 100 years old—whereas physics is more than 2,000 years old. 'Relative to physics, neuroscience is still in its Pythagorean Theorem stage,' he jokes.
There's still a lot we don't know about the brain and, as a result, how memory works. But Ramirez and neuroscientists like him are turning science fiction into science reality, which may allow us to one day edit and manipulate our own experiences. More importantly, their research helps us understand the profound ways that memory shapes us—and how we might begin to shape it right back.
This article is part of Your Memory, Rewired, a National Geographic exploration into the fuzzy, fascinating frontiers of memory science—including advice on how to make your own memory more powerful. Learn more.
The nonprofit National Geographic Society, committed to illuminating and protecting the wonder of our world, funded National Geographic Explorer Steve Ramirez's work. Learn more about the Society's support of Explorers.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

China Is Building an AI Robot Uterus, and Are We Just Basically ‘Dune' Now?
China Is Building an AI Robot Uterus, and Are We Just Basically ‘Dune' Now?

Gizmodo

time2 hours ago

  • Gizmodo

China Is Building an AI Robot Uterus, and Are We Just Basically ‘Dune' Now?

In a development that completely demolishes the line between robotics and reproductive science, China's Kaiwa Technology says it has introduced humanoid robots equipped with advanced artificial womb systems. What could possibly go wrong with this line of experimentation? Well, those of you who are Dune fans know exactly where this could theoretically go: a future filled with robots that take over humanity and have to be defeated and then outlawed in order to keep civilization going. But we should back up a little before we jump right to that. Let's first look a little closer at what Kaiwa says it has done thus far. It says it has a 'late stage' prototype that combines artificial intelligence with bioengineering and mimics the hormonal and physical processes of pregnancy. The robots have biosynthetic organs that the company claims are capable of simulating gestation in a controlled environment, including feeding an embryo or fetus via liquid nutrients. Kaiwa claims its womb-endowed robots will eventually retail for about $14,000, as SlashGear reports. How to Build an Artificial Womb Kaiwa has not disclosed whether it's running tests on biological material or with human eggs, sperm, or embryos. It also does not explain how an actual baby would be born. Well, the first and most obvious thing is that a robotic uterus could easily damage or terminate a fetus if it does not work correctly. Babies are not hydroponic, after all, and depend on a complex mixture of nutrients and signals from the highly complicated placenta, which is really the workhorse of pregnancy (aside from the pregnant person carrying the fetus). Creating an AI placenta would be much more of a Holy Grail in science than a robotic womb, because it grows, changes, and expands as the fetus develops and is far more delicate and difficult to replicate. Kaiwa did not respond to a request for comment. It has not said whether it is also developing a humanoid placenta or if that is already part of the robot uterus. 'This is a revolutionary step,' Kaiwa said in a statement. 'Our robots could help scientists explore the intricacies of gestation and, someday, provide alternatives to biological reproduction.' More worrying, there have been very few reports of any ethical vetting of what Kaiwa is using to test this new technology or how advanced it is. There is serious ethical debate over the future of human reproduction and how a robotic component would affect the relationships and ownership of embryos or children conceived or delivered that way, particularly in countries like the U.S., in which some states recognize embryos as property. The pros? If true and ethically vetted, this new technology could potentially open new avenues for infertility research and reproductive assistance. It could provide surrogacy at a much reduced cost of around $14,000 (the cost of the robot) for people who can't have a child, compared to a human surrogacy fee of about $100,000 to $200,000 in the U.S. The cons? The patchwork of laws applying to reproductive tech is a changing pattern depending on the country, the region, the governing bodies (like the European Union), cultural roles, religious rules, and the rights of parenthood and surrogates. Who would own each part of the process of creating a human fetus in a robot would have to be exhaustively studied and debated, and it would very likely fall short of most definitions of bioethical standards. Who then oversees that process and enforces its rules should there be infractions is a whole other ball of legal and ethical wax. The prospect of these robots being artificially intelligent raises another important issue. Super-sophisticated robots may eventually be granted personhood status, meaning they'd be protected under the same laws as human beings. And should these robots eventually feel and experience emotions in a manner similar to humans, that would introduce yet another layer of ethical and legal complexity. An artificial womb could also help human babies survive extreme prematurity and prevent serious complications like brain injuries, lung damage, or blindness. Indeed, advances in neonatal care may drive this technology forward, regardless of any overt attempt to create a robotic uterus. Conversely, critics worry about the potential misuse or dehumanization of the gestation process, noting that artificial wombs could lead to creating 'human-like entities' without full biological rights or moral considerations. 'Pregnancy is an extremely complex process, with each step being extremely delicate and critical,' Yi Fuxian, an obstetrician at the University of Wisconsin–Madison, told Newsweek. He said the robot is 'likely just a gimmick' and that synthetic gestation has caused problems in sheep, and that 'many health risks emerge at different ages, not to mention mental health issues.' Recent reporting has found that China and South Korea's tech sectors are watching the pregnancy robot saga closely. South Korea already has robots as 10% of its workforce. In January 2024, its Ministry of Trade, Industry, and Energy unveiled the Fourth Intelligent Robot Basic Plan, which will plow $2.24 billion in public and private investments by 2030 to advance automation across most business sectors. Countries with declining birth rates like Japan and South Korea may also be major marketplaces for a synthetic uterus. South Korea has declared its lack of babies a national emergency and has been attempting to lure people into becoming parents with a new ministry focused on providing housing, immigration, and other demographic markers that may be keeping people from having any or more children. The county has already invested more than $200 billion in fertility programs over the last 18 years, but thus far the birth rate has stayed low. Maybe having a government-subsidized pregnancy robot could change that.

Digital Science's 2025 Catalyst Grant seeking innovations to 'see the future' with data visualization
Digital Science's 2025 Catalyst Grant seeking innovations to 'see the future' with data visualization

Yahoo

time10 hours ago

  • Yahoo

Digital Science's 2025 Catalyst Grant seeking innovations to 'see the future' with data visualization

Teams working at intersection of science, design and data could win up to £25,000 for new tech ideas LONDON, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Digital Science, a technology company serving stakeholders across the research ecosystem, today launches its Catalyst Grant round for 2025 to support innovative tech ideas. Now in its 15th year, the theme for Digital Science's 2025 Catalyst Grant is: Data visualization. Up to £25,000 will be awarded to individuals or startups for their technology-driven ideas. The deadline to apply is Monday 6 October 2025. Steve Scott, Director of Portfolio Development at Digital Science, said: 'With the rapid growth of AI, data science, and open research, visualization is emerging as a vital tool to aid research impact. In today's data-rich, attention-poor world, how we understand and communicate data is just as important as what the data says. 'This year, the Digital Science Catalyst Grant challenges innovators to push the boundaries of data visualization, not just as a communication tool, but as a driver for prediction, insight, and action. 'We want to 'see the future' through data; we want visualizations to be used as a process for discovery. To do this, we're looking for game-changers who are turning raw data into intuitive stories, elegant dashboards, and predictive visuals that empower researchers, institutions, funders, and decision-makers alike.' About Catalyst Grant The Digital Science Catalyst Grant is an international initiative to support innovation in new software tools and technologies, to advance research and create meaningful change. The program supports and invests in early-stage ideas in the novel use of technology, with an award of up to £25,000 for the most promising ideas that aid research and further its impact on society. The Catalyst Grant is awarded to innovative individuals or startups without the need for a complete business or development plan. Several previous Catalyst Grant winners have developed important products and solutions within Digital Science itself. Data Visualization – the 2025 Catalyst Grant focus For Catalyst Grant 2025, Digital Science is looking for novel applications of data visualization technology that can benefit any aspect of the research ecosystem and lifecycle, and any stakeholders Digital Science serves. These include: researchers, universities, funders, industry, and publishers. We're seeking tools and technologies that: Model complex data to uncover hidden patterns, trends and predictive insights Use advanced technologies, including AI and machine learning, to uncover patterns that traditional analysis might miss Visualize high-dimensional data to improve understanding and support better decision-making Deliver intuitive web and mobile-first solutions for scientific storytelling or discovery, reducing time-to-insight Create a unique user interface (UI) or user experience (UX) for dashboards, lab tools, or clinical data systems Enable interactive exploration of real-world evidence Apply for the Digital Science Catalyst Grant The Digital Science Catalyst Grant is now open for entries. Key details: Visit the Digital Science Catalyst Grant website for full eligibility criteria and how to apply Open globally to individuals and startups with early-stage technology ideas Questions about the Catalyst Grant to be directed to: catalyst@ Deadline: 12pm BST / 7am EDT, Monday 6 October 2025. Find out more about Catalyst Grant. Join the conversation on social media with: #CatalystGrant About Digital Science Digital Science is an AI-focused technology company providing innovative solutions to complex challenges faced by researchers, universities, funders, industry and publishers. We work in partnership to advance global research for the benefit of society. Through our brands – Altmetric, Dimensions, Figshare, IFI CLAIMS Patent Services, metaphacts, OntoChem, Overleaf, ReadCube, Symplectic, and Writefull – we believe when we solve problems together, we drive progress for all. Visit and follow Digital Science on Bluesky, on X or on LinkedIn. CONTACT: Media contact David Ellis, Press, PR & Social Manager, Digital Science: Mobile +61 447 783 023,

ASX Penny Stocks Spotlight: Berkeley Energia And 2 Other Noteworthy Picks
ASX Penny Stocks Spotlight: Berkeley Energia And 2 Other Noteworthy Picks

Yahoo

time16 hours ago

  • Yahoo

ASX Penny Stocks Spotlight: Berkeley Energia And 2 Other Noteworthy Picks

Australian shares are experiencing a downturn, with the ASX 200 futures showing a slight decline amid cautious sentiment surrounding the government's Economic Reform Roundtable and reactions to Wall Street's recent highs. In such uncertain market conditions, investors often look beyond established names to explore opportunities in smaller or newer companies. Penny stocks, despite being considered an outdated term, continue to intrigue investors with their potential for growth at lower price points. Top 10 Penny Stocks In Australia Name Share Price Market Cap Financial Health Rating Alfabs Australia (ASX:AAL) A$0.45 A$124.67M ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$2.49 A$117.93M ★★★★★★ GTN (ASX:GTN) A$0.4025 A$77.22M ★★★★★★ IVE Group (ASX:IGL) A$2.965 A$461M ★★★★★☆ West African Resources (ASX:WAF) A$2.715 A$3.09B ★★★★★★ Regal Partners (ASX:RPL) A$3.10 A$1.05B ★★★★★★ Bravura Solutions (ASX:BVS) A$2.08 A$927.98M ★★★★★★ Austco Healthcare (ASX:AHC) A$0.37 A$137.06M ★★★★★★ Bisalloy Steel Group (ASX:BIS) A$4.51 A$218.27M ★★★★★★ CTI Logistics (ASX:CLX) A$1.855 A$149.41M ★★★★☆☆ Click here to see the full list of 450 stocks from our ASX Penny Stocks screener. Let's review some notable picks from our screened stocks. Berkeley Energia Simply Wall St Financial Health Rating: ★★★★★★ Overview: Berkeley Energia Limited focuses on the exploration and development of mineral properties in Spain with a market capitalization of A$245.19 million. Operations: Currently, the company does not report any revenue segments. Market Cap: A$245.19M Berkeley Energia, with a market cap of A$245.19 million, is currently pre-revenue and focuses on mineral exploration in Spain. The company has transitioned to profitability this year and maintains a debt-free status, contrasting its previous debt to equity ratio of 55.3% five years ago. Its seasoned board and management team bring significant experience, with average tenures of 13.3 and 9.8 years respectively. Despite low Return on Equity at 1.2%, Berkeley's strong asset position covers both short-term (A$80.1M) and long-term liabilities (A$1.8M), while shareholders have not faced meaningful dilution recently. Click here and access our complete financial health analysis report to understand the dynamics of Berkeley Energia. Review our historical performance report to gain insights into Berkeley Energia's track record. Core Lithium Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Core Lithium Ltd focuses on developing lithium and various metal deposits in Northern Territory and South Australia, with a market cap of A$278.59 million. Operations: The company's revenue is primarily generated from the Finniss Lithium Project, contributing A$52.28 million. Market Cap: A$278.59M Core Lithium, with a market cap of A$278.59 million, is focused on developing lithium projects in Australia and generated A$52.28 million from its Finniss Lithium Project. The company remains unprofitable and is not expected to achieve profitability in the next three years despite revenue growth forecasts of 39.2% annually. Core Lithium has a stable financial position with short-term assets (A$60.7M) exceeding both short-term (A$32.5M) and long-term liabilities (A$14.6M). The management team averages 1.3 years in tenure, suggesting recent changes, while the board has more experience with an average tenure of 8.4 years. Get an in-depth perspective on Core Lithium's performance by reading our balance sheet health report here. Understand Core Lithium's earnings outlook by examining our growth report. PolyNovo Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally with a market cap of A$832.47 million. Operations: The company generates revenue of A$115.58 million from the development, manufacturing, and commercialisation of its NovoSorb Technology. Market Cap: A$832.47M PolyNovo, with a market cap of A$832.47 million, has demonstrated significant earnings growth of 270.2% over the past year, surpassing its 5-year average and industry benchmarks. The company's recent sales report shows revenue climbing to A$118.6 million for Fiscal Year 2025, a notable increase from the previous year. Despite this growth, PolyNovo's management team is relatively inexperienced with an average tenure of 1.6 years, and it faces challenges such as negative operating cash flow and low return on equity at 7.8%. However, strong short-term assets cover both short-term and long-term liabilities effectively. Navigate through the intricacies of PolyNovo with our comprehensive balance sheet health report here. Gain insights into PolyNovo's outlook and expected performance with our report on the company's earnings estimates. Where To Now? Discover the full array of 450 ASX Penny Stocks right here. Contemplating Other Strategies? Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:BKY ASX:CXO and ASX:PNV. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store